Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

Definition Coronary heart disease (CHD) is the leading cause of mortality worldwide. One of
the main contributions of mortality and morbidity in CHD patients is acute myocardial …

Background Severe coronavirus-induced disease 2019 (COVID-19) leads to acute
respiratory distress syndrome with an increased risk of venous thrombo-embolic events. To …

COVID‐19 was primarily identified as a respiratory illness, but reports of patients presenting
initially with cardiovascular complaints are rapidly emerging. Many patients also develop …

Abstract Severe coronavirus (COVID-19) infection has been reportedly associated with a
high risk of thromboembolism. Developing macrovascular thrombotic complications …

Abstract A Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has become
a pandemic disease named Coronavirus Disease-19 (COVID-19) of epochal dimension …

Coronavirus disease 2019 (COVID-19), a respiratory syndrome, is a global pandemic.
Therefore, there is an urgent need to explore mechanisms implicated in the pathogenesis of …

The world is in a hard battle against COVID-19. Endothelial cells are among the most critical
targets of SARS-CoV-2. Dysfunction of endothelium leads to vascular injury following by …

An outbreak of SARS-CoV-2 infection in December 2019 became a major global concern in
2020. Since then, several articles analyzing the course, complications and mechanisms of …

OBJECTIVE: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also
known as COVID-19, a viral outbreak that started in December 2019, eventually lead to a …